Genetic amplification and overexpression of the WWP1 E3 ubiquitin ligase, which degrades KLF5 protein, also frequently occur in human prostate cancer [56,57], causing excess protein degradation and insufficiency of KLF5. This evidence concerns the gene KLF5 and prostate cancer.